SCHEMBL17967366

SCHEMBL17967366

CC(=Cc1ccccc1)c1ccc(C)cc1N

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NFE2L2 Q16236 1/20 0.42
ALDH1A1 P00352 4/20 0.40
ALOX15 P16050 2/20 0.40
HSD17B10 Q99714 1/20 0.40
MAPT P10636 2/20 0.40
NPC1 O15118 1/20 0.40
POLB P06746 1/20 0.40
RAB9A P51151 1/20 0.40
TDP1 Q9NUW8 2/20 0.39
TP53 P04637 1/20 0.39
CYP3A4 P08684 1/20 0.39
THRB P10828 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TSHR P16473 1/20 0.38
AKR1C3 P42330 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
KDM1A O60341 1/20 0.37
NISCH Q9Y2I1 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17967365 1.00 NFE2L2 (0.42) NFE2L2ALDH1A1ALOX15HSD17B10MAPT
SCHEMBL17967354 0.87 MAPT (0.43) NFE2L2ALDH1A1ALOX15HSD17B10MAPT
SCHEMBL17967356 0.87 MAPT (0.43) NFE2L2ALDH1A1ALOX15HSD17B10MAPT
SCHEMBL6546334 0.83 NFE2L2 (0.55) NFE2L2ALDH1A1MAPTNPC1POLB
SCHEMBL20799495 0.81 PTGS2 (0.44) NFE2L2ALDH1A1ALOX15HSD17B10MAPT
SCHEMBL21808157 0.80 MAPT (0.49) ALDH1A1HSD17B10MAPTTSHRAKR1C3
SCHEMBL21808158 0.80 MAPT (0.49) ALDH1A1HSD17B10MAPTTSHRAKR1C3
SCHEMBL3668138 0.78 CSNK2A1 (0.50) NFE2L2MAPTNPC1POLBRAB9A
SCHEMBL20474259 0.74 KMT2A (0.52) NFE2L2ALDH1A1HSD17B10MAPTNPC1
SCHEMBL20474258 0.74 KMT2A (0.52) NFE2L2ALDH1A1HSD17B10MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10227355-B2 Quinoline derivatives and preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2019-03-12 US claimed
US-20180237448-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-08-23 US claimed
WO-2016125187-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-08-11 WO claimed
US-10227355-B2 Quinoline derivatives and preparation thereof COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2019-03-12 US disclosed
US-20180237448-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF COUNCIL OF SCIENTIFIC AND INDUSTRIAL RESEARCH (IN) 2018-08-23 US disclosed
WO-2016125187-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF COUNCIL OF SCIENTIFIC & INDUSTRIAL RESEARCH (IN) 2016-08-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180237448-A1 NOVEL QUINOLINE DERIVATIVES AND PREPARATION THEREOF ABL1, FLT3, MAP3K7 NFE2L2 623/4885ALDH1A1 1992/4885ALOX15 4719/4885
US-10227355-B2 Quinoline derivatives and preparation thereof ABL1, FLT3, MAP3K7 NFE2L2 736/4885ALDH1A1 2096/4885ALOX15 4743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.